Neoantigen quality, not quantity
Abstract
Prioritizing expressed clonal neoantigens in genes required for cancer cell survival may reduce the likelihood of resistance to neoantigen therapies.
Journal details
Journal Science Translational Medicine
Volume 11
Issue number 506
Pages eaax7918
Publication date
Full text links
Publisher website (DOI) 10.1126/scitranslmed.aax7918
Europe PubMed Central 31434757
Pubmed 31434757
Keywords
Related topics
Type of publication